Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNabilone or dihydrocodeine for chronic neuropathic pain?
British Medical Journal, 01/25/08
Frank B et al. - To compare the analgesic efficacy and side effects of the synthetic cannabinoid nabilone with those of the weak opioid dihydrocodeine for chronic neuropathic pain. Dihydrocodeine provided better pain relief than the synthetic cannabinoid nabilone and had slightly fewer side effects, although no major adverse events occurred for either drug.
Related Articles
Chronic pain in adults after thoracotomy in childhood or youth
British Journal of Anesthesia, 11/16/09
Relevance Score: 81%
Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State
Journal of Opioid Management, 11/03/09
Relevance Score: 81%
Topical capsaicin for chronic neuropathic pain in adults
Cochrane Reviews, 10/08/09
Relevance Score: 81%
Characterization of chronic pain patients in German pain centers. Core data from more than 10,000 patients
Schmerz, 10/06/09
Relevance Score: 81%
Targeting Voltage-Gated Calcium Channels for Neuropathic Pain Management
Neurotherapeutics, 10/05/09
Relevance Score: 80%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09
Blood Pressure, but Not Cerebrospinal Fluid Fentanyl Concentration, Predicts Duration of Labor Analgesia from Spinal Fentanyl
Anesthesiology, 12/11/09
Bupivacaine Inhibits Glutamatergic Transmission in Spinal Dorsal Horn Neurons
Anesthesiology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor